Erratum: Management of Hepatocellular Carcinoma: Current Status and Future Directions
نویسندگان
چکیده
In the version of this article initially published, at the bottom of the left column on page 442, the number " 18 " was inadvertently replaced by " 8 " during the publication process. The correction is given below (marked in bold): Page 442, left column From: Score: <18=increased mortality ≥8=better candidate for TACE To: Score: <18=increased mortality ≥18=better candidate for TACE This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License
منابع مشابه
Status of serum alpha feto-protein (AFP) and midkine (MDK) levels in patients with hepatocellular carcinoma
Introduction: Hepatocellular carcinoma (HCC) is sixth common cancers worldwide and predominant in Asia and Africa. A number of evidence suggests a possible role of midkine (MDK) and α-fetoprotein (AFP) in the pathogenesis of hepatocellular carcinoma (HCC). Materials and methods: We studied MDK and AFP in patients with HCC or in healthy controls. MDK and AFP was measured by enzyme linked immuno...
متن کاملAflatoxins and aflatoxigenic fungi in Iran: A systematic review of the past, present, and future
Aflatoxins are highly toxic compounds that are produced as secondary metabolites by some Aspergillus and Emericella species. Despite huge progress on aflatoxin research during the past 50 years, we have witnessed many cases of food contamination with aflatoxins all over the world. Aflatoxins have mutagenic and carcinogenic effects and they are capable of inducing hepatocellular carcinoma in hum...
متن کاملManagement of Hepatocellular Carcinoma: Current Status and Future Directions
Hepatocellular carcinoma (HCC) is the second most common cause of cancer death worldwide. This cancer commonly arises against a background of chronic liver disease. As a result, a patient with HCC requires multidisciplinary care. Treatment options vary widely based on tumor burden and metastases. The most widely utilized staging system is the Barcelona Clinic Liver Cancer staging system, which ...
متن کاملTargeted therapy for hepatocellular carcinoma: current status and future direction
Following the proof of evidence on the use of sorafenib in patients with advanced hepatocellular carcinoma (HCC), targeted therapy has become an important element in management of advanced HCC. Novel targeted therapies are designed to inhibit the aberrant signaling pathways or oncogenic mechanism at a molecular level with an aim to improve the clinical outcome. An increasing number of targeted ...
متن کاملPatient Engagement and its Evaluation Tools – Current Challenges and Future Directions; Comment on “Metrics and Evaluation Tools for Patient Engagement in Healthcare Organization- and System-Level Decision-Making: A Systematic Review”
Considering the growing recognition of the importance of patient engagement in healthcare decisions, research and delivery systems, it is important to ensure high quality and efficient patient engagement evaluation tools. In this commentary, we will first highlight the definition and importance of patient engagement. Then we discuss the psychometric properties of the patient engagement evaluati...
متن کامل